Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20924709 | 0.94 | HTT (0.42) | HTTKMT2AGAAUSP2KDM4E | |
| SCHEMBL17213635 | 0.93 | HTT (0.44) | HTTKMT2AGAAUSP2KDM4E | |
| SCHEMBL15262817 | 0.89 | HTT (0.41) | HTTKMT2AGAAUSP2KDM4E | |
| SCHEMBL15263166 | 0.88 | GAA (0.41) | HTTKMT2AGAAUSP2KDM4E | |
| SCHEMBL15262286 | 0.88 | GAA (0.41) | HTTKMT2AGAAUSP2KDM4E | |
| SCHEMBL15262108 | 0.88 | KDM4E (0.40) | HTTKMT2AGAAUSP2KDM4E | |
| SCHEMBL15263080 | 0.88 | HTT (0.40) | HTTKMT2AGAAUSP2KDM4E | |
| SCHEMBL15262684 | 0.87 | GAA (0.41) | HTTKMT2AGAAUSP2KDM4E | |
| SCHEMBL15262729 | 0.87 | USP2 (0.41) | HTTKMT2AGAAUSP2KDM4E | |
| SCHEMBL15262190 | 0.87 | GAA (0.41) | HTTKMT2AGAAUSP2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9921473-B2 | Aromatic glycol ethers as writing monomers in holographic photopolymer formulations | COVESTRO DEUTSCHLAND AG (DE) | 2018-03-20 | — | — | US | disclosed |
| US-9921473-B2 | Aromatic glycol ethers as writing monomers in holographic photopolymer formulations | COVESTRO DEUTSCHLAND AG (DE) | 2018-03-20 | — | — | US | disclosed |
| US-20170045816-A1 | AROMATIC GLYCOL ETHERS AS WRITING MONOMERS IN HOLOGRAPHIC PHOTOPOLYMER FORMULATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2017-02-16 | — | — | US | disclosed |
| US-20170045816-A1 | AROMATIC GLYCOL ETHERS AS WRITING MONOMERS IN HOLOGRAPHIC PHOTOPOLYMER FORMULATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2017-02-16 | — | — | US | disclosed |
| WO-2015161969-A1 | AROMATIC GLYCOL ETHERS AS WRITING MONOMERS IN HOLOGRAPHIC PHOTOPOLYMER FORMULATIONS | BAYER MATERIAL SCIENCE AG (DE) | 2015-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170045816-A1 | AROMATIC GLYCOL ETHERS AS WRITING MONOMERS IN HOLOGRAPHIC PHOTOPOLYMER FORMULATIONS | MARK3, KDM3A, MAP1LC3B | HTT 416/4885KMT2A 363/4885GAA 1294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.